Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Christy J. Wilson
Sr. Director, Pharma and Biotech Segment
Connect with Christy J. Wilson on LinkedIn
Follow Christy J. Wilson on Twitter
About the author:
Christy brings more than 20 years of global life science and healthcare industry experience to her role as Senior Director, Segment Marketing for the biopharmaceutical industry segment at Elsevier. In this capacity she is focused on understanding biopharmaceutical R&D challenges and the implications for Elsevier in terms of market led growth opportunities that will improve productivity and success for industry executives and their teams. She also plays a key role in increasing Elsevier’s share-of-voice and market share through strategic go-to-market planning and execution.
Prior to joining Elsevier, Christy held senior marketing and business development roles in Wolters Kluwer’s Pharma Solutions Business Unit where she was responsible for product management and marketing of the Adis portfolio of drug focused journals and newsletters, pipeline and clinical trials intelligence tools, and pharmacovigilance solutions. During her Wolters Kluwer tenure, Christy also worked in the group’s Healthcare Analytics business, a business that provided powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market.
Christy resides in the greater New York City area and holds an MBA in International Business from DePaul University (Chicago) and a BS in Marketing, from Miami University (Ohio).
Posts by Christy J. Wilson
Posted on October 25th, 2017 in Chemistry
In many people’s minds, the classic image of the chemist is still someone in a lab coat standing over a burner, while chemistry itself tends to evoke thoughts of equations on chalkboards and fluids in beakers. But the reality is that these images are a bit outdated Continue reading “Chemists: Unsung Innovators” »
Posted on October 11th, 2017 in Pharma R&D
Researchers are always looking for new ways to attack cancer, and the scientists at Boston-based biotech start-up Rubius Therapeutics have happened upon an unexpected ally: the red blood cell.
Posted on September 20th, 2017 in Pharmacovigilance
Traditionally thought of as a post-market process, pharmacovigilance is how pharmaceutical companies monitor and address any safety issues that arise once a drug becomes available commercially. However, some companies are now thinking ahead about these potential safety concerns with what is known as “proactive PV”. Continue reading “Big Data and Proactive Pharmacovigilance” »
Posted on March 13th, 2017 in Pharma R&D
Precision medicine, which takes the individual into account like never before, has been a thrilling development in the field of medicinal research. It is an area that has shown particular promise in the treatment of cancer, Continue reading “Making Medicine More Precise” »